FDA tells Purell to stop claiming it can prevent flu

Marketing campaign also claims product can prevent ebola spread


The Food and Drug Administration (FDA) told the maker of Purell to discontinue marketing campaigns that includes claims for avoiding flu and ebola, according to an article on The New York Times website.

The campaigns also claim the product can prevent spread of MRSA and norovirus.

The FDA told Gojo Industries that its claims that Purell could reduce the potential for infection or prevent illnesses violated the Federal Food, Drug and Cosmetic Act. 

The agency said it was reclassifying Purell as an unapproved drug, rather than an over-the-counter product.

Read the article.



February 10, 2020


Topic Area: Infection Control

Recent Posts

Charging Ahead: Incentives Driving EV Charging in Healthcare Facilities

Manufacturers discuss how incentives impact the decision-making process.

Outpatient Growth and the Future of Healthcare Real Estate

From shifting services off hospital campuses to investing in purpose-built outpatient facilities, the healthcare sector is evolving rapidly.

Mount Sinai South Nassau Opens Expanded Emergency Department

$50 million renovation designed to reduce wait times and improve patient experience; includes 54 private exam rooms.

Lehigh Valley Health Network to Open Fourth Neighborhood Hospital in 2026

The project is a three-story, 90,000-square-foot building, with the hospital occupying the first floor and medical offices on the two upper floors.

Creating an Emergency Preparedness Plan with NFPA 99

Digital tools and codebooks can relay pertinent information faster to facility professionals.

 
 


FREE Newsletter Signup Form

News & Updates | Webcast Alerts
Building Technologies | & More!

 
 
 


All fields are required. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.